SLShuo Liu

Shuo Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuo Liu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Lina Wang

    School of Stomatology, Dalian Medical University, Dalian 116044, China

    5 shared publications
  • Weidong Niu

    School and Hospital of Stomatology, Dalian Medical University, Dalian 116044, China

    4 shared publications
  • Ming Dong

    School and Hospital of Stomatology, Dalian Medical University, Dalian 116044, China

    3 shared publications
  • Ao Lu

    Department of Endodontics and Periodontics, School of Stomatology, Dalian Medical University, Dalian, Liaoning, China; Academician Laboratory of Immune and Oral Development & Regeneration, Dalian Medical University, Dalian, Liaoning, China

    2 shared publications
  • Gege Zhang

    School of Stomatology, Dalian Medical University, Liaoning, 116044, China

    2 shared publications
  • Shuixiang Guo

    School of Stomatology, Dalian Medical University, Liaoning, 116044, China

    2 shared publications

Latest Publications

  • Open Access

    Icariin-Loaded Milk-Derived Extracellular Vesicles: Protective Effect on Inflammatory Bone Defects via HIF-1α

    by Ming Dong, Xinxin Yu, Shuo Liu, Yue Han, Wenqing Han, Lina Wang, Weidong Niu

    Objective: Icariin (ICA) is an active small molecule extracted from Epimedium, possessing therapeutic potential for inflammatory bone destruction. Small extracellular vesicles (MEVs) derived from bovine milk are safe and efficient drug delivery carriers. We aimed to explore the potential of ICA-loaded bovine milk EVs (ICA-MEVs) to repair inflammatory bone defects in an inflammatory microenvironment and investigated the underlying molecular mechanism, providing new ideas for the treatment of inflammatory bone defects. Methods: We fabricated icariin (ICA)-loaded milk-derived extracellular vesicles (ICA-MEVs) embedded in GelMA hydrogel and systematically evaluated the in vivo repairing efficacy against lipopolysaccharide (LPS)-induced inflammatory calvarial bone defects via micro-CT, HE staining, Masson staining and immunohistochemistry. Subsequent in vitro cellular experiments were carried out to uncover the regulatory mechanism by which ICA-MEVs promotes LPS-inhibited osteoblast proliferation and osteogenic differentiation. Results: ICA-MEVs significantly promoted the repair of inflammatory bone defects, upregulated osteogenic factors such as BMP-2, OCN, and Runx-2, and reduced the levels of IL-1β and TNF-α. ICA-loaded MEVs facilitated the proliferation and osteogenic differentiation of MC3T3-E1 osteoblasts while alleviating cellular inflammatory activation. Mechanistically, ICA-MEVs promoted bone repair by elevating LIM1 expression. Elevated LIM1 bound to the endogenous HIF-1α promoter and triggered subsequent transcriptional activation of HIF-1α. Conclusions: Under inflammatory conditions, ICA-MEVs effectively promoted the proliferation and differentiation of MC3T3-E1 cells and inhibited the expression of inflammatory factors. Mechanistically, ICA-MEVs upregulated HIF-1α transcription and expression by potentiating the LIM1-mediated transcriptional activation of the HIF-1α promoter, thereby facilitating inflammatory bone repair. Although milk-derived EVs exhibited favorable safety profiles in this preclinical study, comprehensive detection of immunogenicity and long-term adverse reactions will be necessary in follow-up research to support clinical transformation.

  • Open Access

    A radix dipsaci-loaded gelatin methacryloyl nanocomposite hydrogel with slow release and osteogenic effects

    by ShuiXiang Guo, GeGe Zhang, Ao Lu, QianYang Chen, QiYu Qu, Miao Liu, Shuo Liu, WeiDong Niu, LiNa Wang


  • Open Access

    Hmong medicine tooth-fixing formula promotes bone repair in periodontitis

    by Ming Dong, Shuo Liu, Haibo Sun, Meichen Tong, Qianyang Chen, Shuixiang Guo, Gege Zhang, Chun Shi, Lina Wang, Weidong Niu


  • Open Access

    Identification and validation of endoplasmic reticulum autophagy-related potential biomarkers in periodontitis

    by Ruyue Wang, Jinyue Hu, Qing Sun, Shuixiang Guo, Gege Zhang, Ao Lu, Shuo Liu, Xue Yang, Lina Wang

    Periodontitis is a chronic inflammatory disease that mainly occurs in the dental supporting tissues. Endoplasmic reticulum autophagy (ER-phagy) is a new type of selective autophagy. The main function of ER-phagy is to degrade excess ER membranes or toxic protein aggregates, control the volume of ER, and maintain cell homeostasis. This study utilized bioinformatics to identify and validate potential ER-phagy-related biomarkers for periodontitis. The relationship between immune cell infiltration and periodontitis as well as potential biomarkers was analyzed, to identify new targets for the diagnosis and treatment of periodontitis. Data from GeneCards and Gene Expression Omnibus (GEO) databases were utilized to identify differentially-expressed ER-phagy-related genes, and to conduct functional enrichment and pathway analyses. Random forest, least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature removal (SVM-RFE) algorithms were used to identify hub genes. Receiver operating characteristic (ROC) curves and areas under the curve (AUCs) were calculated to assess diagnostic performance and identify potential biomarkers for periodontitis. The CIBERSORT deconvolution algorithm was used to study the link between potential biomarkers and distinct types of immune cells. In addition, clinical samples were examined using Real-time quantitative polymerase chain reaction (RT-qPCR) to verify the expression of genes related to ER-phagy in periodontitis and identify a signature which may better predict this disease. Bioinformatics analysis identified 88 differentially-expressed ER-phagy-related genes (DE-ERGs). 6 hub genes were found using LASSO, SVM-RFE and Random forest, namely ATP1A1, CD69, DNAJB11, GANAB, IL7, and PSME2. ATP1A1 and GANAB exhibited robust diagnostic efficacy in both the training set and validation set. The results of immune cell infiltration analysis revealed a significantly greater abundance of plasma cells in periodontitis tissue samples compared to healthy periodontal tissue samples (P < 0.05). Correlation analysis between potential biomarkers and immune cells demonstrated that the expression levels of ATP1A1 and GANAB were correlated with plasma cells and resting dendritic cells. Clinical samples examined by RT-qPCR verified that these ER-phagy-related signature genes in periodontitis may better predict the development of periodontitis.ER-phagy is closely related to the pathological process of periodontitis. The infiltration of immune cells differs between tissues affected by periodontitis and healthy periodontal tissues, and a variety of immune cell subsets are significantly correlated with ATP1A1 and GANAB, thus ATP1A1 and GANAB have good diagnostic efficiency for periodontitis and can be used as potential biomarkers for early diagnosis.


  • Open Access

    Molecular Mechanism of the Asarum–Angelica Drug Pair in the Treatment of Periodontitis Based on Network Pharmacology and Experimental Verification

    by Qianyang Chen, Yuhan Wang, Chun Shi, Meichen Tong, Haibo Sun, Ming Dong, Shuo Liu, Lina Wang

    (1) To examine the potential mechanism of the Asarum–Angelica drug pair against periodontitis and provide an experimental basis for the treatment of periodontitis with herbal medicine. (2) The core components and core targets of the Asarum–Angelica drug pair in the treatment of periodontitis were detected according to network pharmacology methods. Finally, the effect of the Asarum–Angelica drug pair on osteogenic differentiation was observed in mouse embryonic osteoblast precursor cells. (3) According to the results of network pharmacology, there are 10 potential active ingredients in the Asarum–Angelica drug pair, and 44 potential targets were obtained by mapping the targets with periodontitis treatment. Ten potential active ingredients, such as kaempferol and β-sitosterol, may play a role in treating periodontitis. Cell experiments showed that the Asarum–Angelica drug pair can effectively promote the expression of osteoblast markers alkaline phosphatase (ALP), Runt-related Transcription Factor 2 (RUNX2), and BCL2 mRNA and protein in an inflammatory environment (p < 0.05). (4) Network pharmacology effectively analyzed the molecular mechanism of Asarum–Angelica in the treatment of periodontitis, and the Asarum–Angelica drug pair can promote the differentiation of osteoblasts.


  • Open Access

    Milk-Derived Small Extracellular Vesicles Promote Osteogenic Differentiation and Inhibit Inflammation via microRNA-21

    by Runyuan Liu, Shuo Liu, Saixuan Wu, Meng Xia, Wanqing Liu, Lina Wang, Ming Dong, Weidong Niu

    Chronic apical periodontitis (CAP) is a disease with characteristics of inflammation and bone loss. In this study, our objective was to examine the function of small extracellular vesicles (sEVs) obtained from milk in encouraging osteogenic differentiation and inhibiting inflammation by miR-21 in CAP. The expression of miR-21 was detected using qRT-PCR in human CAP samples. The impact of miR-21 on the process of osteogenic differentiation was investigated using CCK-8, qRT-PCR, immunofluorescence staining, and Western blot analysis. The evaluation of RAW 264.7 cell polarization and the assessment of inflammatory factor expression were conducted through qRT-PCR. The influence of sEVs on MC3T3-E1 cells and RAW 264.7 cells was examined, with a particular emphasis on the involvement of miR-21. In human CAP samples, a decrease in miR-21 expression was observed. MiR-21 increased the expression of osteogenesis-related genes and M2 polarization genes while decreasing the expression of M1 polarization genes and inflammatory cytokines. Treatment with milk-derived sEVs also promoted osteogenesis and M2 polarization while inhibiting M1 polarization and inflammation. Conversely, the addition of miR-21 inhibitors resulted in opposite effects. Our results indicated that sEVs derived from milk had a positive effect on bone formation and activation of anti-inflammatory (M2) macrophages and simultaneously reduced inflammation by regulating miR-21 in CAP.